ArticleFrontiers in immunology2026
Ficoll-based isolation biases the profiling of immune cells and leukemic blasts in AML samples.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: An increasing number of studies focus on anti-tumor immune responses. In acute myeloid leukemia (AML), blasts and immune cells, such as T cells, are frequently studied together in the same leukocyte sample. While hemolysis is the clinical standard for leukocyte isolation because it preserves the native leukocyte composition, Ficoll-based density gradient centrifugation is widely used in research and biobanking. Methods: Using hemolysis as a reference, we assessed whether Ficoll processing introduces biases into AML and immune cell profiling through analytical methods frequently applied in AML research. Results: Flow cytometry analyses showed that Ficoll systematically alters the composition of AML samples by enriching lymphocytes and AML blasts while depleting granulocytes. In RNA sequencing analysis, Ficoll isolation altered the expression of 1,136 genes, notably leading to an overestimation of the expression of leukemic stem cell gene sets. Immunogenomic deconvolution highlighted that Ficoll leads to an overestimation of CD8 Discussion: Together, these findings show that Ficoll isolation introduces bias in the cellular and molecular characterization of AML samples while having only a moderate impact on functional assays. We provide recommendations on which method to use depending on the investigator's objectives.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.